Trials / Completed
CompletedNCT01178918
Non-specific Response to H1N1 Vaccine
Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- The University Clinic of Pulmonary and Allergic Diseases Golnik · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
Conditions
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-12-01
- Completion
- 2012-07-01
- First posted
- 2010-08-10
- Last updated
- 2020-02-28
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT01178918. Inclusion in this directory is not an endorsement.